Skip to content

Comparison of ESWT versus acupuncture in treatment of myofascial trigger points in calf muscle

Comparison of ESWT versus Dry Needling in treatment of myofascial trigger points in calf muscle

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230801058995N1
Enrollment
84
Registered
2023-10-03
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial trigger point. Myalgia

Interventions

Intervention 1: The first intervention group is subjected to shockwave therapy, which is provided once a week for three consecutive weeks. Shockwave therapy using Storz medical masterpulse MP100 devic

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 16 and 60 years Patient satisfaction Having at least one active trigger point in the cuff area Duration of symptoms for at least 6 months

Exclusion criteria

Exclusion criteria: Presence of neurological defects (weakness, paresthesia, etc.) History of lumbar discopathy, lumbar disc herniation, myopathy, fibromyalgia, spondylosis, spinal canal stenosis Current drug treatments or physical therapy, surgery and injection in trigger point in the last 6 months Simultaneous painful disorders so that the main complaint of the patient is simultaneous pain Mental disorder Rheumatological diseases

Design outcomes

Primary

MeasureTime frame
Pain variable is evaluated by two scales.PPT is calculated by using a digital algometer by applying vertical pressure to the trigger points. In order to stimulate the patient's pain, the pressure is increased at a rate of 1Kg/Cm2/s and the subjective reports of the people are recorded. The place of maximum pain is at a distance of 1 minute will be checked again.Visual analog scale (VAS) measures the intensity of the patient's pain. Validation and reliability studies have been done. The VAS scale is divided into 10 vertical or horizontal lines from zero (no pain) to 10 points (the most severe pain).n of general health, vitality, social role function, limitation in emotional function and health. It is fluent. The checklist is attached.Visual analog scale (VAS) measures the intensity of the patient's pain. Validation and reliability studies have been done. The VAS scale is divided into 10 vertical or horizontal lines from zero (no pain) to 10 points (the most severe pain). Timepoint: VAS and PPT variables are completed for each patient immediately after completing three sessions of shock wave and dry needling, and then one month and three months after the completion of the interventions. Also, the VAS variable is checked again six months after the end of the interventions. Method of measurement: PPT is calculated using a digital algometer (Brandwagner) by applying vertical pressure to the trigger points. In order to stimulate the patient's pain, the pressure is increased at a rate of 1 Kg/Cm2/s and the subjective reports of the people are recorded.The VAS scale is divided into 10 vertical or horizontal lines from zero (no pain) to 10 points (the most severe pain).

Secondary

MeasureTime frame
The quality of life is measured by the 36-item short form (SF-36), which is the most widely used general quality of life scale in the medical field. It includes 8 sub-categories, which are 36 items in total, and evaluates physical and mental health in general. The sub-categories include physical function, difficulty in performing physical activity, pain, perceptio. Timepoint: It is completed immediately after three sessions of shock wave and dry needling, and then one month and three months after the completion of the interventions for each patient. Method of measurement: In this study, the quality of life is calculated by the SF-36 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTannaz Ahadi

Iran University of Medical Sciences

tannaz.ahadi@yaho.com+98 21 8214 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026